William D. Mc Clellan Jr. Reata Pharmaceuticals Inc (RETA) insider trading activity

William D. Mc Clellan Jr. is Director of REATA PHARMACEUTICALS INC. Currently has a direct ownership of 0 shares of RETA, which is worth approximately $0. The most recent transaction as insider was on Sep 26, 2023, when has been sold 6,017 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

William D. McClellan Jr. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 26 2023	SELL Sale (or disposition) back to the issuer	-	6,017 Reduced 100.0%	0 Class A Common Stock
Jul 28 2023	SELL Open market or private sale	$822,450 $164.49 p/Share	5,000 Reduced 45.38%	6,017 Class A Common Stock
Jul 28 2023	BUY Conversion of derivative security	-	5,000 Added 31.22%	11,017 Class A Common Stock
Jun 07 2023	BUY Grant, award, or other acquisition	$167,374 $93.61 p/Share	1,788 Added 22.91%	6,017 Class A Common Stock
Jun 08 2022	BUY Grant, award, or other acquisition	$144,949 $34.76 p/Share	4,170 Added 49.65%	4,229 Class A Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	$1,612 $27.32 p/Share	59 Added 50.0%	59 Class A Common Stock
Nov 12 2020	SELL Open market or private sale	$693,960 $173.49 p/Share	4,000 Reduced 100.0%	0 Class A Common Stock
Nov 12 2020	BUY Conversion of derivative security	-	4,000 Added 50.0%	4,000 Class A Common Stock
Nov 09 2020	SELL Open market or private sale	$600,040 $150.01 p/Share	4,000 Reduced 100.0%	0 Class A Common Stock
Nov 09 2020	BUY Conversion of derivative security	-	4,000 Added 50.0%	4,000 Class A Common Stock

Also insider at

APEN

Apollo Endosurgery, Inc. Healthcare

Director

WDM